Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-042163
Filing Date
2017-06-28
Accepted
2017-06-28 17:49:43
Documents
2
Period of Report
2017-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1623
2 EX-24 DOCUMENT attachment1.htm EX-24 4950
  Complete submission text file 0001209191-17-042163.txt   8200
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Issuer) CIK: 0000873303 (see all company filings)

EIN.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 DUPONT DR IRVINE CA 92612
Business Address
INGRAM DOUGLAS S (Reporting) CIK: 0001190644 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-14895 | Film No.: 17936355